Related Experiment Video

Updated: Jul 7, 2026

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

Can contrast-enhanced US with targeted microbubbles monitor the response to antiangiogenic therapies?

Jonathan B Kruskal1

  • 1Department of Radiology, Beth Israel Deaconess Medical Center, One Deaconess Rd, Boston, MA 02215, USA. jkruskal@bidmc.harvard.edu

Radiology
|January 30, 2008
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Related Experiment Videos

Last Updated: Jul 7, 2026

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

Small language models in clinical medicine: a systematic review of performance, safety, and deployment feasibility.

Journal of the American Medical Informatics Association : JAMIA·2026

Reference quality of OpenEvidence across five medical specialties.

npj health systems·2026

OpenEvidence errs on the safe side in a structured test of triage recommendations.

International journal of medical informatics·2026

Non-Conscious Detection of "Missed" Lung Nodules by Radiologists: Expanding the Boundaries of Successful Processing During the Visual Assessment of Chest CT Scans.

Radiology·2025

Spectrum of Cognitive Biases in Diagnostic Radiology.

Radiographics : a review publication of the Radiological Society of North America, Inc·2024

Peer learning in abdominal radiology: iterative process improvements over a 20-year experience.

Abdominal radiology (New York)·2023

How I Do It: An Imaging Approach and Review of Autoimmune Encephalitis.

Radiology·2026

Intraindividual Comparison of Radiation Dose and Image Quality: Photon-counting versus Energy-integrating Detector CT in Obesity.

Radiology·2026

Redistribution of Pulmonary Vascular Volume at Upright versus Supine CT.

Radiology·2026

No Reflow at Perfusion Imaging: Thresholds That Distinguish Functional and Tissue Outcome Groups in Acute Stroke.

Radiology·2026

Association of PET/CT Metabolic Parameters with Histologic Grade of Lung Adenocarcinoma: Implications for Surgical Decisions.

Radiology·2026

Myocardial T1 Mapping at 3 T: A Comparison of MOLLI and ShMOLLI across Healthy Volunteers and Various Cardiovascular Pathologies.

Radiology·2026

Calcineurin-mediated regulation of macrophage plasticity drives anti-tumor activity.

Molecular therapy. Advances·2026

EXO1 inhibition selectively kills replication repair-deficient cancer cells.

NAR cancer·2026

Biotics-based modulation of gastric precancerous states: microbial, metabolic, and epithelial mechanisms.

Frontiers in immunology·2026

Pan-cancer biomarkers of immune therapy resistance: mechanisms and clinical translation.

Frontiers in cell and developmental biology·2026

DYRK1A - a gene dose paradox.

Frontiers in cell and developmental biology·2026

Visualizing the distribution of durvalumab targeting PD-L1 using quantitative fluorescence imaging in patients with esophageal cancer.

Theranostics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us